市场调查报告书
商品编码
1434618
过敏诊断市场:按类型、产品类型、测试、最终用户划分 - 2024-2030 年全球预测Allergy Diagnostics Market by Type (Drug Allergen, Food Allergen, Inhaled Allergen), Product Type (Assay Kits, Consumables, Instruments), Test, End User - Global Forecast 2024-2030 |
※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。
预计2023年过敏诊断市场规模为59.2亿美元,2024年达64.9亿美元,2030年预计将达118亿美元,复合年增长率为10.35%。
全球过敏诊断市场
主要市场统计 | |
---|---|
基准年[2023] | 59.2亿美元 |
预测年份 [2024] | 64.9亿美元 |
预测年份 [2030] | 118亿美元 |
复合年增长率(%) | 10.35% |
过敏诊断是由合格的专业人员进行的测试,以确定患者的身体是否对已知化学物质过敏。过敏诊断测试可估算您体内通常与过敏相关的抗体和蛋白质的数量。随着异位性皮肤炎、荨麻疹和过敏性结膜炎等过敏性疾病的增加,对准确过敏诊断的需求也预计会增加。人群中多种过敏性疾病的发生导致人们越来越偏好早期检测和诊断过敏原,从而需要有效的诊断测试和系统。然而,对过敏性疾病的认识有限、诊断测试成本高昂以及训练有素的专业人员有限可能会阻碍预测期内的市场开拓。此外,该公司开始专注于开发基于人工智慧和机器学习的新过敏诊断测试和套件的研究工作,创造市场发展机会。
区域洞察
欧洲因其发达的製药工业和不断增长的治疗药物需求而在过敏诊断市场中占据重要地位。老年人口的增加和过敏性疾病的增加也促进了该地区的成长。在美洲,由于呼吸道过敏性疾病的高发病率、过敏诊断意识层级的提高以及试管内血液检测的采用,预计该市场在未来几年将增长。 FDA 一直在指导食品业、消费者和其他相关人员如何最好地评估和控制食品中过敏原的风险。生技药品评估与研究中心 (CBER) 负责监管多种促进北美市场成长的过敏原产品。由于医疗基础设施的快速改善、未满足的临床需求以及对微创诊断工具的需求,预计亚太地区将成为成长最快的区域市场。由于阿联酋生产和出口过敏诊断所需的设备和耗材的主要零件,沙乌地阿拉伯预计将在过敏诊断市场中成长。
FPNV定位矩阵
FPNV定位矩阵对于评估过敏诊断市场至关重要。我们检视与业务策略和产品满意度相关的关键指标,以对供应商进行全面评估。这种深入的分析使用户能够根据自己的要求做出明智的决策。根据评估,供应商被分为四个成功程度不同的像限:前沿(F)、探路者(P)、利基(N)和重要(V)。
市场占有率分析
市场占有率分析是一种综合工具,可以对过敏诊断市场中供应商的现状进行深入而深入的研究。全面比较和分析供应商在整体收益、基本客群和其他关键指标方面的贡献,以便更好地了解公司的绩效及其在争夺市场占有率时面临的挑战。此外,该分析还提供了对该行业竞争特征的宝贵见解,包括在研究基准年观察到的累积、分散主导地位和合併特征等因素。这种详细程度的提高使供应商能够做出更明智的决策并制定有效的策略,从而在市场上获得竞争优势。
1-市场渗透率:提供有关主要企业所服务的市场的全面资讯。
2-市场开拓:我们深入研究利润丰厚的新兴市场并分析其在成熟细分市场的渗透率。
3- 市场多元化:提供有关新产品发布、开拓地区、最新发展和投资的详细资讯。
4-竞争力评估与资讯:对主要企业的市场占有率、策略、产品、认证、监管状况、专利状况、製造能力等进行全面评估。
5- 产品开发与创新:提供对未来技术、研发活动和突破性产品开发的见解。
1-过敏诊断市场的市场规模和预测是多少?
2-在过敏诊断市场的预测期内,有哪些产品、细分市场、应用和领域需要考虑投资?
3-过敏诊断市场的技术趋势和法律规范是什么?
4-过敏诊断市场主要供应商的市场占有率为何?
5-进入过敏诊断市场的合适型态和策略手段是什么?
[187 Pages Report] The Allergy Diagnostics Market size was estimated at USD 5.92 billion in 2023 and expected to reach USD 6.49 billion in 2024, at a CAGR 10.35% to reach USD 11.80 billion by 2030.
Global Allergy Diagnostics Market
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 5.92 billion |
Estimated Year [2024] | USD 6.49 billion |
Forecast Year [2030] | USD 11.80 billion |
CAGR (%) | 10.35% |
An allergy diagnosis is a test performed by a qualified specialist to determine if the patient's body is allergic to known chemicals. Allergy diagnostics tests estimate the number of typical antibodies or proteins in the body that are associated with allergies. Rising cases of allergic diseases such as atopic dermatitis, hives, and allergic conjunctivitis are expected to elevate the need for accurate allergy diagnosis. The incidence of multiple allergic diseases among the population expands the preference for early detection and diagnosis of the allergen, creating a requirement for effective diagnostic tests or systems. However, limited awareness about allergic diseases and high costs of diagnostic tests, and the limited availability of trained professionals can impede the market development over the forecast period. Furthermore, the emerging emphasis on research activities to develop new allergy diagnostic tests or kits based on AI and ML by companies is creating an opportunity for market development.
Regional Insights
Europe has a significant landscape in the allergy diagnostics market due to a developed pharmaceutical industry and increasing demand for therapeutics. The growing geriatric population and rising incidences of allergic conditions also contribute to the region's growth. The market is expected to grow in the Americas in coming years owing to the high incidence of respiratory allergic disorders, rising awareness levels about allergy diagnostics, and the adoption of in vitro blood tests. The FDA has guided the food industry, consumers, and other stakeholders on the best ways to assess and manage allergen hazards in food. The Center for Biologics Evaluation and Research (CBER) regulates several allergenic products that contributed to market growth in North America. Asia-Pacific is expected to be the fastest-growing regional market due to rapidly improving healthcare infrastructure, unmet clinical needs, and demand for minimally invasive diagnostic tools. Saudi Arabia has a growing landscape in the allergy diagnostics market, as the UAE manufactures and exports major parts of instruments and consumables required for allergy diagnostics.
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Allergy Diagnostics Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Allergy Diagnostics Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Allergy Diagnostics Market, highlighting leading vendors and their innovative profiles. These include ALK-Abello A/S, Allergy Therapeutics PLC, Astra Biotech GmbH, Bausch & Lomb Incorporated, Biomerieux SA, Danaher Corporation, Dr. Fooke-Achterrath Laboratorien GmbH, DST Diagnostische Systeme & Technologien GmbH, Erba Group, Eurofins Scientific, EUROIMMUN Medizinische Labordiagnostika AG, HAL Allergy B.V., Hitachi, Ltd., HOB Biotech Group Corp., Ltd., HollisterStier by Jubilant Life Sciences Limited, HYCOR Biomedical, Lincoln Diagnostics, Inc., Minaris Medical America, Inc., Neogen Corporation, Omega Diagnostics Group PLC, Parkway Pantai Ltd., R-Biopharm AG, Romer Labs Division Holding GmbH by Royal DSM, ROXALL Medizin GmbH, Siemens AG, Stallergenes Greer International AG, Tecan Trading AG, and Thermo Fisher Scientific Inc..
Market Segmentation & Coverage
1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
1. What is the market size and forecast of the Allergy Diagnostics Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Allergy Diagnostics Market?
3. What are the technology trends and regulatory frameworks in the Allergy Diagnostics Market?
4. What is the market share of the leading vendors in the Allergy Diagnostics Market?
5. Which modes and strategic moves are suitable for entering the Allergy Diagnostics Market?